Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px
Document › Details

Biolin Scientific AB. (2/5/15). "Press Release: Biolin Scientific and Nanion Technologies Have Entered into a Licensing Agreement". Stockholm & Munich.

Organisations Organisation Biolin Scientific AB
  Group Ratos (Group)
  Organisation 2 Nanion Technologies GmbH
  Group Nanion (Group)
Products Product patch clamp system
  Product 2 data analysis s/w (bioinformatics)
Index terms Index term Nanion–Ratos: patch clamp technology, 201502– license non-excl to key patent providing freedom-to-operate for life time of patent from Biolin
  Index term 2 Ratos–Xention: patch clamp technology, 201501 acquisition key patent by Biolin Scientifc from Xention Ltd
Persons Person von Heijne, Johan (Ratos 201501 CEO of Biolin Scientific)
  Person 2 Fertig, Niels (Nanion Technologies GmbH 201102 Managing Director CEO)
     


Biolin Scientific Holding AB, Sweden and Nanion Technologies GmbH, Germany today announce that the parties have entered into a licensing agreement. Biolin Scientific has agreed to grant a non-exclusive license for the key patent related to performing multi-hole, high-throughput ion channel screening to Nanion Technologies in exchange for an undisclosed license fee. The non-exclusive license will provide Nanion Technologies with freedom to operate for the entire life time of the patents.

The patent describes a method for ensuring high quality data by analyzing multiple cells and thus multiple sets of ion channels under one experimental condition, thus providing extremely high quality data and a truly high-throughput screening method.

Johan von Heijne, President and CEO of Biolin Scientific states, “This deal affirms our commitment to invest in high-throughput screening using automated patch clamping, and our intent to vigorously protect our broad range of innovations and intellectual property rights. We are committed to our full range of brands including Sophion, Q-Sense, Attension and KSV NIMA branded products”.

Niels Fertig, CEO of Nanion Technologies comments, “The license agreement is fully in-line with our long-term strategy to safeguard our ability to continue to develop new and exciting products in the field of automated patch clamping”.


About Biolin Scientific

Biolin Scientific is a leading Nordic instrumentation company with revenues of 240 million SEK and part of Ratos AB (publ). Our premium solutions help the pharmaceutical industry to discover new drugs and treatments. Companies working with energy, chemicals and advanced materials use our technologies for material characterization and quality control. Our precision instruments also support academic research institutes in their studies of the frontiers of science and technology.

Biolin Scientific proprietary systems are based on nanotechnology and advanced measurement techniques, which have earned leadership in several industries through their commitment to scientific excellence and continuous product development. Our commitment to customer service and application support is a key feature of our operations. We focus on working together with customers and building long-lasting relations. Today, Biolin Scientific provides products and services in more than 70 countries around the world. Our portfolio consists of the following brands: Attension, KSV NIMA, Q-Sense and Sophion.


About Nanion Technologies

Nanion Technologies was founded in 2002 as a spin-off from the University of Munich, Center for Nanoscience (CeNS). Over the last 13 years it has grown to a strong company with over 80 employees worldwide. Nanion has its headquarters in Munich, Germany, and has daughter companies in the USA and China, with distribution partners in 7 other countries, including Japan. Nanion has been recognized for its quality and innovation by being twice nominated for the Federal President’s Award for Technology and Innovation (Deutscher Zukunftspreis) in 2007 and 2014. The company has become known for its high quality instruments for ion channel research (Port-a-Patch, Patchliner and SyncroPatch product families) and has over the years expanded its product range to include cardiotoxicity screening (CardioExcyte 96), parallel bilayer recordings (Orbit 16), and parallel membrane transporter protein recordings (SURFE2R). Since 2014, Nanion carries Axion’s multi-electrode array (MEA) systems in Europe and China.


Contact:

Johan von Heijne
CEO Biolin Scientific
johan.vonheijne@biolinscientific.com
+46 70 595 15 10

Niels Fertig
CEO Nanion Technologies GmbH
niels@nanion.de
+49 89 218997972

   
Record changed: 2017-04-02

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

More documents for Ratos (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top